J. Pharm. Technol. Res. Manag.

Microneedle Mediated Vaccine Delivery: A Comprehensive Review

Anureet Arora, Manju Nagpal and Geeta Aggarwal


vaccine, immune, epitope, antigen, transcutaneous, pathogenic

PUBLISHED DATE November 2017
PUBLISHER The Author(s) 2017. This article is published with open access at www.chitkara.edu.in/publications

Microneedles can be representative for paradigm shift of drug delivery from patient non-compliant parenteral injections to patient compliant drug delivery system, which can be utilized for administration of vaccines particularly along with macromolecular/micromolecular drugs. The concept of microneedles came into existence many decades ago but the use of microneedles to achieve efficient delivery of drugs into the skin became subject of research from mid of 1990’s. Various types of microneedles were utilized to enhance delivery of drugs and vaccines including solid microneedles for pre-treatment of skin to enhance drug permeability, dissolvable polymeric microneedles encapsulating drugs, microneedles coated with drugs and hollow microneedles for infusion of drugs through the skin. Microneedles have shown promising delivery of vaccines through skin in literature. But the successful utilization of this system for vaccine drug delivery mainly depends on design of device to facilitate microneedle infusion, vaccine stability and storage in system, recovery of skin on removal of microneedle and improved patient compliance. This article reviews the conventional and advanced methods of vaccine drug deliver, microneedles for drug delivery, types of microneedles, advantages of microneedles and potential of microneedles for vaccine drug delivery.

Page(s) 149–162
URL http://dspace.chitkara.edu.in/jspui/bitstream/123456789/668/1/JPTRM%205-2-4.pdf
ISSN Print : 2321-2217, Online : 2321-2225
DOI 10.15415/jptrm.2017.52011
  • Akhtar, N (2014). Microneedles: an innovative approach to transdermal deliverya review. Int J Pharm Pharm Sci, 6(4), 0975–1491.
  • Alarcon, J.B., Hartley, A.W., Harvey, N.G., Mikszta, J.A (2007). Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clinc Vacc Immunol, 14, 375–381. https://doi.org/10.1128/CVI.00387-06
  • Apostolopoulos, V., Stojanovska, L (2013). Targeting Antigens to Dendritic Cell Receptors for Vaccine Development. J Drug Del, Article ID 869718. https://doi.org/10.1155/2013/869718
  • Boks, M.A., Unger, W.W.J., Engels, S., Regina Luttge, R., et. al (2015). Controlled release of a model vaccine by nanoporous ceramic microneedle arrays. Int J Pharm, 491, 375–383. https://doi.org/10.1016/j.ijpharm.2015.06.025
  • Donnelly, R., Douroumis, D (2015). Microneedles for drug and vaccine delivery and patient monitoring. Drug Deliv. Transl. Res, 5, 311–312. https://doi.org/10.1007/s13346-015-0250-2
  • Chen, G., Hao, B (2015). Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis. Acta PharmaceuticaSinicaB, 5(6), 569–576. https://doi.org/10.1016/j.apsb.2015.09.006
  • Chen, M.C., Ling, M.H., Lai, K.Y., Pramudityo, E (2012). Chitosan microneedle patches for sustained transdermal delivery of macromolecules. Biomacromol, 13(12), 4022–4031. https://doi.org/10.1021/bm301293d
  • Cormier, M., Johnson, B., Ameri, M., Nyam, K (2004). Transdermal delivery of desmopressin using a coated micro needle array patches system. J Control Rel, 97, 503–511. https://doi.org/10.1016/S0168-3659(04)00171-3
  • Coulman, S., Allender, C., Birchall, J (2006). Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit Rev Ther Drug Carrier Syst, 23, 205–258. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v23.i3.20
  • Courtenay, A.J., Donnelly, R.F (2016). Microneedles: A New Frontier in Nanomedicine Delivery. Pharm Res, 33, 1055–1073. https://doi.org/10.1007/s11095-016-1885-5
  • Desale, R.S., Wagh, K.S., Akarte, A.M., Baviskar, D.T. et al (2012). Microneedles technology for advanced drug delivery: a review. Int J Pharm Tech Res, 4(1), 181–189. http://www.who.int/influenza_vaccines_plan/resources/deployment/en/
  • Donnelly, R.F., Morrow, D.I.J., McCarron, P.A., Woolfson, A.D., et. al (2009). Microneedle arrays permit enhanced intradermal delivery of a performed photosensitizer. Photochem Photobiol, 85, 195–204. https://doi.org/10.1111/j.1751-1097.2008.00417.x
  • Donnelly, R.F., Thakur, R.R.S., Woolfson, A.D (2010). Microneedle based drug delivery system: Microfabrication, drug delivery and safety. Drug Deliv, 17(4), 187–207. https://doi.org/10.3109/10717541003667798
  • Duan, D., Moeckly, C., Gysbers, J., Novak, C (2013). Enhanced delivery of topically-applied formulations following skin pre treatment with a hand-applied, plastic microneedle array. Curr Drug Del, 8(5), 557–565. https://doi.org/10.2174/156720111796642318
  • Ghosh, P., Pinninti, R.R., Hammell, D.C., Paudel, K.S (2013). Development of a codrug approach for sustained drug delivery across microneedles-treatment skin. J Pharm Sci, 102(5), 1458–1467. https://doi.org/10.1002/jps.23469
  • Gill, H.S., Prausnitz, M.R (2007). Coated microneedles for transdermal delivery. J Control Release, 117(2),227–237. https://doi.org/10.1016/j.jconrel.2006.10.017
  • Gill, H.S., Prausnitz, M.R (2007). Coating formulations for microneedles. Pharm Res, 24, 1369–1380. https://doi.org/10.1007/s11095-007-9286-4
  • Ita, K (2015). Transdermal Delivery of Drugs with Microneedles–Potential and Challenges. Pharmaceutics, 7, 90–105. https://doi.org/10.3390/pharmaceutics7030090
  • Ito, Y., Haguiwara, E., Saeki, A., Sugioka, N. et al (2006). Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci, 29(1), 82–88. https://doi.org/10.1016/j.ejps.2006.05.011
  • Jiskoot, W., Bouwstra,J (2012). Microneedle technologies for transdermal drug and vaccine delivery. J Control Rel, 161, 645–655. https://doi.org/10.1016/j.jconrel.2012.01.042
  • Kocchar, J.S., Zou, S., Chan, S.Y., Kang, L (2012). Protein encapsulation in polymeric microneedles by photolithography. Int J Nanomed, 7, 3143–3154.
  • Kolli, C.S., Banga, A.K (2008). Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res, 25, 104–113. https://doi.org/10.1007/s11095-007-9350-0
  • Saroja, C.H., Lakshmi, P.K., Bhaskaran, S (2011). Recent trends in vaccine delivery systems: A review. IntJ PharmInvestig, 1(2), 64–74. https://doi.org/10.4103/2230-973X.82384
  • Lax, R (2010). Challenges for therapeutic peptides part 2: Delivery Systems. Innov Pharm Tech, 43, 42–46.
  • Lee, J.W., Sullivan, S.P (2010). Dissolving polymer microneedle patches for influenza vaccination. Nat Med, 16(8), 915–920. https://doi.org/10.1038/nm.2182
  • Matriano, J.A., Cormier, M., Johnson, J., Young, W.A., Buttery, M., Nyam, K., Daddona, P.E.(2002). Macroflux Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization. Pharm Res, 19(1), 63–70. https://doi.org/10.1023/A:1013607400040
  • McAllister, D.V., Allen, M.G., Prausnitz, M.R (2000). Microfabricated microneedles for gene and drug delivery. Ann Rev Biomed Eng, 2, 289–313. https://doi.org/10.1146/annurev.bioeng.2.1.289
  • Milewski, M., Brogden, N.K., Stinchcomb, A.L (2010) Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. Expert Opin Drug Deliv, 7(5), 617–629. https://doi.org/10.1517/17425241003663228
  • Mortanto, W., Davis, S.P., Holiday, N.R., Wang, J. et al (2004). Transdermal delivery of insulin using microneedles in vivo. Pharm Res, 21(6), 945–952. https://doi.org/10.1023/B:PHAM.0000029282.44140.2e
  • Park, J.H., Allen, M.G., Prausnitz, M.R (2006) Polymer microneedles for controlled-release drug delivery. Pharm Res, 23,1008–1019. https://doi.org/10.1007/s11095-006-0028-9
  • Park, J.H., Allen, M.G (2005). Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Rel, 104(1), 51–66. https://doi.org/10.1016/j.jconrel.2005.02.002
  • Pawar, R.G., et al (2012). Microneedles: novel approach to transdermal drug delivery system. J Drug Del Ther, 2(1), 76–80. https://doi.org/10.22270/jddt.v2i1.77
  • Prausnitz, M.R (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev, 56, 581–587. https://doi.org/10.1016/j.addr.2003.10.023
  • Prausnitz, M.R., Allen, M.G., Henry, S., Mcallister, D.V., et al (2004). Devices and methods for enhanced microneedle penetration of biological barriers. US006743211.
  • Prausnitz, M.R., john, A., Cormier, M.M., Andrianov, A.K (2009). Microneedles based vaccines. Curr Top Microbiol Immunol, 333, 369–393. https://doi.org/10.1007/978-3-540-92165-3_18
  • Qiu, Y., Qin, G., Zhang, S., Wu, Y., et al (2012). Novel lyophilized hydrogel patches for convenient and effective administration of microneedle-mediated insulin delivery. Int J Pharm, 437, 51–56. https://doi.org/10.1016/j.ijpharm.2012.07.035
  • Quinn, H.L., Kearney, M.C., Courtenay, A.J., McCrudden, M.T., Donnelly, R.F (2014). The role of microneedles for drug and vaccine delivery. Expert Opin. Drug Deliv, 11(11), 1–12. https://doi.org/10.1517/17425247.2014.938635
  • Raphael, A.P., Prow, T.W., Crichton, M.L., Chen, X., Fernando, G.J., Kendall, M.A. (2010). Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small, 6, 1785–1793. https://doi.org/10.1002/smll.201000326
  • Roxhed. N (2007). A Fully Integrated Microneedle-based Transdermal Drug Delivery System, 064, 1653–5146.
  • Raphael, A.P., Crichton, M.L., Falconer,R.J., Meliga, S., Chen, X., Fernando, G.J., Huang, H., Kendall, M.A. (2016). Formulations for microprojection/microneedle vaccine delivery: Structure, strength and release profiles. J ControlRel, 225, 40–52. https://doi.org/10.1016/j.jconrel.2016.01.027
  • Schwendener, R.A (2014). Liposomes as vaccine delivery systems: a review of the recent advances. Ther Adv Vaccines, 2(6), 159–182. https://doi.org/10.1177/2051013614541440
  • Song, Jae-Min., Kim,Yeu-Chun (2012). DNA Vaccination in the Skin Using Microneedles Improves Protection Against Influenza. Molecular Therapy, 20(7), 1472–1480. https://doi.org/10.1038/mt.2012.69
  • Srinivas, P., Shanthi, C.L., Sadanandam, M.S (2010). Miconeedles patches in drug delivery: a review. Int J Pharm Tech, 2(3), 329–344.
  • Stanley, K.A., Smith, K.M (2013). Vaccine delivery with microneedle skin patches in nonhuman primates. Nature biotechnology, 31(12),1082–1085. https://doi.org/10.1038/nbt.2759
  • Suh, H., Shin,J (2014). Microneedle patches for vaccine delivery. Clin Exp Vaccine Res, 3, 42–49. https://doi.org/10.7774/cevr.2014.3.1.42
  • Wermeling, D.P., Banks, S.L., Hudson, DA., Gupta, J. et al (2008). Microneedles permit transdermal delivery of a skin impermeant medication to humans. Proc Natl Acad Sci USA, 105(6), 2058–2063. https://doi.org/10.1073/pnas.0710355105
  • Woolfson, A.D., Donnelly, R.F (2012). Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Rel, 159, 52–59. https://doi.org/10.1016/j.jconrel.2012.01.003
  • Wu, M.X., Shah. D (2012). Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J ControlRel, 159, 43–51. https://doi.org/10.1016/j.jconrel.2012.01.002
  • Yuzhakov, V.V (2007). Microneedle array, patch, and applicator for transdermal drug delivery. US20070161964 .
  • Yuzhakov, V.V (2010). Advanced delivery devices: The AdminPenTM Microneedle device for painless and convenient drug delivery. Drug Deliv Tech, 10(4), 32–36.